Microsoft (NASDAQ:MSFT) may have just fired the starting gun on a new race in healthcare AI. In a recently unveiled study, the company introduced its AI Diagnostic Orchestrator, a tool designed to tackle complex medical cases with the help of a virtual team of five specialized AI agents. In benchmark tests against 304 real-world cases from the New England Journal of Medicine, the orchestrator, powered by OpenAI’s o3 model, nailed the correct diagnosis in 85.5% of cases.
